Althoughα-fetoprotein (AFP) was originally considered a useful tumor marker for patient screening or monitoring for hepatocellular carcinoma (HCC) and yolk sac tumor7,8, it is known that some malignancies such as colorectal and lung cancer can produce also AFP9–12. This evidence concerns the gene AFP and neoplasm.